Cargando…
Inhibition of experimental autoimmune uveitis by intravitreal AAV-Equine-IL10 gene therapy
Equine recurrent uveitis (ERU) is a spontaneous, painful, and vision threatening disease affecting up to 25% of equine populations worldwide. Current treatments of ERU are non-specific and have many side effects which limits them to short-term use. In order to develop an effective therapy for ERU, w...
Autores principales: | Crabtree, Elizabeth, Uribe, Katy, Smith, Sara M., Roberts, Darby, Salmon, Jacklyn H., Bower, Jacquelyn J., Song, Liujiang, Bastola, Prabhakar, Hirsch, Matthew L., Gilger, Brian C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387812/ https://www.ncbi.nlm.nih.gov/pubmed/35980983 http://dx.doi.org/10.1371/journal.pone.0270972 |
Ejemplares similares
-
AAV-mediated expression of HLA-G1/5 reduces severity of experimental autoimmune uveitis
por: Crabtree, Elizabeth, et al.
Publicado: (2019) -
Ocular Tolerability and Immune Response to Corneal Intrastromal AAV-IDUA Gene Therapy in New Zealand White Rabbits
por: Song, Liujiang, et al.
Publicado: (2020) -
Adeno-Associated Virus Mediated Gene Therapy for Corneal Diseases
por: Bastola, Prabhakar, et al.
Publicado: (2020) -
Harnessing the Natural Biology of Adeno-Associated Virus to Enhance the Efficacy of Cancer Gene Therapy
por: Bower, Jacquelyn J., et al.
Publicado: (2021) -
A Fixed-Depth Microneedle Enhances Reproducibility and Safety for Corneal Gene Therapy
por: Gilger, Brian C., et al.
Publicado: (2020)